BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1741 related articles for article (PubMed ID: 28669641)

  • 1. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
    Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
    Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
    Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
    Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
    Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
    Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution.
    Khor LY; Dhakal HP; Jia X; Reynolds JP; McKenney JK; Rini BI; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Sep; 40(9):1224-31. PubMed ID: 27428737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
    Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases.
    Zhang M; Wah C; Epstein JI
    Am J Surg Pathol; 2014 Nov; 38(11):1516-21. PubMed ID: 25140895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up.
    Przybycin CG; McKenney JK; Reynolds JP; Campbell S; Zhou M; Karafa MT; Magi-Galluzzi C
    Am J Surg Pathol; 2014 Sep; 38(9):1260-5. PubMed ID: 25127094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
    Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 88.